223 related articles for article (PubMed ID: 17575158)
1. A peptide selected by biopanning identifies the integrin alphavbeta6 as a prognostic biomarker for nonsmall cell lung cancer.
Elayadi AN; Samli KN; Prudkin L; Liu YH; Bian A; Xie XJ; Wistuba II; Roth JA; McGuire MJ; Brown KC
Cancer Res; 2007 Jun; 67(12):5889-95. PubMed ID: 17575158
[TBL] [Abstract][Full Text] [Related]
2. PET/CT Imaging of NSCLC with a α
Flechsig P; Lindner T; Loktev A; Roesch S; Mier W; Sauter M; Meister M; Herold-Mende C; Haberkorn U; Altmann A
Mol Imaging Biol; 2019 Oct; 21(5):973-983. PubMed ID: 30671741
[TBL] [Abstract][Full Text] [Related]
3. Cyclic alphavbeta6-targeting peptide selected from biopanning with clinical potential for head and neck squamous cell carcinoma.
Hsiao JR; Chang Y; Chen YL; Hsieh SH; Hsu KF; Wang CF; Tsai ST; Jin YT
Head Neck; 2010 Feb; 32(2):160-72. PubMed ID: 19572290
[TBL] [Abstract][Full Text] [Related]
4. Dimerization of a phage-display selected peptide for imaging of αvβ6- integrin: two approaches to the multivalent effect.
Singh AN; McGuire MJ; Li S; Hao G; Kumar A; Sun X; Brown KC
Theranostics; 2014; 4(7):745-60. PubMed ID: 24883124
[TBL] [Abstract][Full Text] [Related]
5. In Vivo PET Imaging of the Cancer Integrin αvβ6 Using
Notni J; Reich D; Maltsev OV; Kapp TG; Steiger K; Hoffmann F; Esposito I; Weichert W; Kessler H; Wester HJ
J Nucl Med; 2017 Apr; 58(4):671-677. PubMed ID: 27980050
[TBL] [Abstract][Full Text] [Related]
6. A Cystine Knot Peptide Targeting Integrin αvβ6 for Photoacoustic and Fluorescence Imaging of Tumors in Living Subjects.
Zhang C; Kimura R; Abou-Elkacem L; Levi J; Xu L; Gambhir SS
J Nucl Med; 2016 Oct; 57(10):1629-1634. PubMed ID: 27230926
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Bi-Terminal PEGylation of an Integrin αvβ₆-Targeted ¹⁸F Peptide on Pharmacokinetics and Tumor Uptake.
Hausner SH; Bauer N; Hu LY; Knight LM; Sutcliffe JL
J Nucl Med; 2015 May; 56(5):784-90. PubMed ID: 25814519
[TBL] [Abstract][Full Text] [Related]
9. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
[TBL] [Abstract][Full Text] [Related]
10. Isolation of multiple cell-binding ligands from different phage displayed-peptide libraries.
Oyama T; Rombel IT; Samli KN; Zhou X; Brown KC
Biosens Bioelectron; 2006 Apr; 21(10):1867-75. PubMed ID: 16386888
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of a suite of tumor targeting peptides for non-small cell lung cancer.
McGuire MJ; Gray BP; Li S; Cupka D; Byers LA; Wu L; Rezaie S; Liu YH; Pattisapu N; Issac J; Oyama T; Diao L; Heymach JV; Xie XJ; Minna JD; Brown KC
Sci Rep; 2014 Mar; 4():4480. PubMed ID: 24670678
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of galectin-1 expression in non-small cell lung cancer patients.
Carlini MJ; Roitman P; Nuñez M; Pallotta MG; Boggio G; Smith D; Salatino M; Joffé ED; Rabinovich GA; Puricelli LI
Lung Cancer; 2014 Apr; 84(1):73-8. PubMed ID: 24560493
[TBL] [Abstract][Full Text] [Related]
13. The roles of integrin αvβ6 in cancer.
Niu J; Li Z
Cancer Lett; 2017 Sep; 403():128-137. PubMed ID: 28634043
[TBL] [Abstract][Full Text] [Related]
14. From phage display to nanoparticle delivery: functionalizing liposomes with multivalent peptides improves targeting to a cancer biomarker.
Gray BP; Li S; Brown KC
Bioconjug Chem; 2013 Jan; 24(1):85-96. PubMed ID: 23186007
[TBL] [Abstract][Full Text] [Related]
15. Expression of beta 1, beta 3, beta 4, and beta 5 integrins by human lung carcinoma cells of different histotypes.
Falcioni R; Cimino L; Gentileschi MP; D'Agnano I; Zupi G; Kennel SJ; Sacchi A
Exp Cell Res; 1994 Jan; 210(1):113-22. PubMed ID: 7505746
[TBL] [Abstract][Full Text] [Related]
16. Integrin αvβ6 predicts poor prognosis and promotes resistance to cisplatin in hilar cholangiocarcinoma.
Sun Q; Dong X; Shang Y; Sun F; Niu J; Li F
Pathol Res Pract; 2020 Jul; 216(7):153022. PubMed ID: 32534716
[TBL] [Abstract][Full Text] [Related]
17. αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer.
Berghoff AS; Kovanda AK; Melchardt T; Bartsch R; Hainfellner JA; Sipos B; Schittenhelm J; Zielinski CC; Widhalm G; Dieckmann K; Weller M; Goodman SL; Birner P; Preusser M
Clin Exp Metastasis; 2014 Oct; 31(7):841-51. PubMed ID: 25150423
[TBL] [Abstract][Full Text] [Related]
18. PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups.
Schmidt LH; Kümmel A; Görlich D; Mohr M; Bröckling S; Mikesch JH; Grünewald I; Marra A; Schultheis AM; Wardelmann E; Müller-Tidow C; Spieker T; Schliemann C; Berdel WE; Wiewrodt R; Hartmann W
PLoS One; 2015; 10(8):e0136023. PubMed ID: 26313362
[TBL] [Abstract][Full Text] [Related]
19. Isolation of lung tumor specific peptides from a random peptide library: generation of diagnostic and cell-targeting reagents.
Oyama T; Sykes KF; Samli KN; Minna JD; Johnston SA; Brown KC
Cancer Lett; 2003 Dec; 202(2):219-30. PubMed ID: 14643452
[TBL] [Abstract][Full Text] [Related]
20. Peptide ligands targeting integrin alpha3beta1 in non-small cell lung cancer.
Lau D; Guo L; Liu R; Marik J; Lam K
Lung Cancer; 2006 Jun; 52(3):291-7. PubMed ID: 16635537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
